Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach
Aberrant histone post-translational modifications (hPTMs) have been implicated with various pathologies, including cancer, and may represent useful epigenetic biomarkers. The data described here provide a mass spectrometry-based quantitative analysis of hPTMs from formalin-fixed paraffin-embedded (F...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-06-01
|
Series: | Data in Brief |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340916300506 |
id |
doaj-3c54917b85f64459b7614bbdb27da51f |
---|---|
record_format |
Article |
spelling |
doaj-3c54917b85f64459b7614bbdb27da51f2020-11-25T00:18:41ZengElsevierData in Brief2352-34092016-06-017188194Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approachRoberta Noberini0Giancarlo Pruneri1Saverio Minucci2Tiziana Bonaldi3Center for Genomic Science of IIT@SEMM, Istituto Italiano di Tecnologia, Via Adamello 16, 20139 Milan, Italy; Co-corresponding authors.School of Medicine, University of Milan, 20122 Milan, Italy; Biobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, ItalyDepartment of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy; Drug Development Program, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy; Department of Bioscience, University of Milan, 20133 Milan, ItalyDepartment of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy; Co-corresponding authors.Aberrant histone post-translational modifications (hPTMs) have been implicated with various pathologies, including cancer, and may represent useful epigenetic biomarkers. The data described here provide a mass spectrometry-based quantitative analysis of hPTMs from formalin-fixed paraffin-embedded (FFPE) tissues, from which histones were extracted through the recently developed PAT-H-MS method. First, we analyzed FFPE samples from mouse spleen and liver or human breast cancer up to six years old, together with their corresponding fresh frozen tissue. We then combined the PAT-H-MS approach with a histone-focused version of the super-SILAC strategy-using a mix of histones from four breast cancer cell lines as a spike-in standard- to accurately quantify hPTMs from breast cancer specimens belonging to different subtypes. The data, which are associated with a recent publication (Pathology tissue-quantitative mass spectrometry analysis to profile histone post-translational modification patterns in patient samples (Noberini, 2015) [1]), are deposited at the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier http://www.ebi.ac.uk/pride/archive/projects/PXD002669. Keywords: Mass spectrometry, Proteomics, Epigenetics, Histone posttranslational modifications, Formalin-fixed paraffin embedded tissues, Biomarker, Breast cancerhttp://www.sciencedirect.com/science/article/pii/S2352340916300506 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Roberta Noberini Giancarlo Pruneri Saverio Minucci Tiziana Bonaldi |
spellingShingle |
Roberta Noberini Giancarlo Pruneri Saverio Minucci Tiziana Bonaldi Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach Data in Brief |
author_facet |
Roberta Noberini Giancarlo Pruneri Saverio Minucci Tiziana Bonaldi |
author_sort |
Roberta Noberini |
title |
Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach |
title_short |
Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach |
title_full |
Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach |
title_fullStr |
Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach |
title_full_unstemmed |
Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach |
title_sort |
mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the pat-h-ms approach |
publisher |
Elsevier |
series |
Data in Brief |
issn |
2352-3409 |
publishDate |
2016-06-01 |
description |
Aberrant histone post-translational modifications (hPTMs) have been implicated with various pathologies, including cancer, and may represent useful epigenetic biomarkers. The data described here provide a mass spectrometry-based quantitative analysis of hPTMs from formalin-fixed paraffin-embedded (FFPE) tissues, from which histones were extracted through the recently developed PAT-H-MS method. First, we analyzed FFPE samples from mouse spleen and liver or human breast cancer up to six years old, together with their corresponding fresh frozen tissue. We then combined the PAT-H-MS approach with a histone-focused version of the super-SILAC strategy-using a mix of histones from four breast cancer cell lines as a spike-in standard- to accurately quantify hPTMs from breast cancer specimens belonging to different subtypes. The data, which are associated with a recent publication (Pathology tissue-quantitative mass spectrometry analysis to profile histone post-translational modification patterns in patient samples (Noberini, 2015) [1]), are deposited at the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier http://www.ebi.ac.uk/pride/archive/projects/PXD002669. Keywords: Mass spectrometry, Proteomics, Epigenetics, Histone posttranslational modifications, Formalin-fixed paraffin embedded tissues, Biomarker, Breast cancer |
url |
http://www.sciencedirect.com/science/article/pii/S2352340916300506 |
work_keys_str_mv |
AT robertanoberini massspectrometryanalysisofhistoneposttranslationalmodificationsinpathologytissueusingthepathmsapproach AT giancarlopruneri massspectrometryanalysisofhistoneposttranslationalmodificationsinpathologytissueusingthepathmsapproach AT saveriominucci massspectrometryanalysisofhistoneposttranslationalmodificationsinpathologytissueusingthepathmsapproach AT tizianabonaldi massspectrometryanalysisofhistoneposttranslationalmodificationsinpathologytissueusingthepathmsapproach |
_version_ |
1725375158455107584 |